Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Recent patents disclose new anticancer agents

July 14, 2008

Preemptive treatment reduces skin toxicities in patients treated with panitumumab

July 11, 2008

Calistoga initiates phase I clinical trial of PI3K delta inhibitor CAL-101

July 11, 2008

Ortho Biotech returns Japanese rights for Yondelis to PharmaMar

July 11, 2008

ValiRx acquires global rights to VAL-201 for prostate cancer

July 11, 2008

Promising activity of GTI-2040 in combination with AraC in acute myeloid leukemia

July 11, 2008

Novel acronycine derivatives with in vivo antitumor activity

July 11, 2008

Merck Serono enrolls first patient in phase II EXPAND trial in gastric cancer

July 10, 2008

Multikinase inhibitor BIBF-1120 profiled at Boehringer Ingelheim

July 10, 2008

Immatics receives research grants for cancer research totaling EUR 1.4 million

July 9, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...